.png){kind=logo}
Introducing Re:Balans®
First-of-its-kind hydration sensor
Our Innovation Partners
This project has received funding from the European Union's Horizon 2020 research and development program under grant agreement No 969065.
This project has also received funding from the European Union's Horizon cybersecurity research and development program under grant agreement No 101094323 - NEMECYS, together with SINTEF.
Impactful innovation
Despite its critical role in the treatment of numerous diseases, effective fluid management remains a significant and unresolved challenge in medical practice.
Re:Balans is currently only available for clinical investigations and research purposes, and are not cleared for medical use in the EU or US.
“This technology is the future of fluid monitoring”
Dr. Solfrid Romunstad, Chief Nephrologist (Helse Midt)
All-in-one, non-invasive sensor
Re:Balans weighs just 15 grams and rests comfortably on the skin, gathering over 50,000 data points daily to track fluid levels.
It offers up to 7 days of continuous, automated, and maintenance-free fluid monitoring.
Third Party Example UI
Monitor and evaluate fluid status
The physician can establish a monitoring target and track the patient's progress together with the standard of care.
This approach can be particularly beneficial in treating patients with fluid management-related health conditions.
By closely monitoring the patient's status together with standard-of-care, the physician can make informed decisions and adjust the treatment plan as needed to ensure optimal outcomes.
Mode In Numbers
12
Employees
5
Years of dev
10M$
Capital invested
10+
Partners